GM-CSF to Decrease ICU Acquired Infections

NCT02361528 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

166

Enrollment

OTHER

Sponsor class

Conditions

Septic Shock
Severe Sepsis

Interventions

DRUG: Sargramostim: Leukine (Genzyme USA)
DRUG: Placebo

Sponsor

Hospices Civils de Lyon